Stocks Intraday Alert: CEL-SCI Corporation (CVM), Sears Holdings Corporation (SHLD), Leucadia National Corporation (LUK)

CEL-SCI Corporation (CVM) managed to rebound with the stock declining -0.08% or $0 to close the day at $0.13 on lower than average trading volume of 2.23M shares, compared to its three month average trading volume of 2.76M. The Vienna Virginia 22182 based company has been outperforming the biotechnology companies by -55.2562% for last three months and its recent losses have trimmed gains to 85.57% YTD, versus the biotechnology industry which is up 0.44% for the same period. The RSI of 55.4 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Sears Holdings Corporation (SHLD) had a active trading with around 2.22M shares changing hands compared to its three month average trading volume of 1.71M. The stock traded between $7.01 and $7.62 before closing at the price of $7.58 with 6.76% change on the day. The Hoffman Estates Illinois 60179 based company is currently trading 37.82% above its 52 week low of $5.5 and -60.36% below its 52 week high of $19.12. Both the RSI indicator and target price of 49.61 and $9 respectively, lead us to believe that it should be put on hold over the coming weeks.

Sears Holdings Corporation operates as a retailer in the United States. It operates in two segments, Kmart and Sears Domestic. The Kmart segment operates retail stores that offer a range of products, including consumer electronics, seasonal merchandise, outdoor living, toys, lawn and garden equipment, food and consumables, and apparel; and in-store pharmacies. It provides merchandise under the Jaclyn Smith, Joe Boxer, and Alphaline labels; Sears brand products, such as Kenmore, Craftsman, and DieHard; and Kenmore-branded products. As of October 31, 2015, this segment operated approximately 952 Kmart stores. The Sears Domestic segment operates stores that provide appliances, consumer electronics/connected solutions, tools, sporting goods, outdoor living, lawn and garden equipment, apparel, footwear, jewelry, and accessories, as well as automotive services and products, such as tires, batteries, and home fashion products. It also offers appliances and services to commercial customers in the single-family residential construction/remodel, property management, multi-family new construction, and government/military sectors; appliance and plumbing fixtures to architects, designers, and new construction or remodeling customers; parts and repair services for appliances, lawn and garden equipment, consumer electronics, floor care products, and heating and cooling systems; and home improvement services, as well as protection agreements and product installation services. This segment provides merchandise under the Kenmore, Craftsman, DieHard, Covington, Canyon River Blues, Metaphor, Outdoor Life, Structure, and Apostrophe brands, as well as under the Roadhandler, Ty Pennington Style, and Alphaline brands. As of October 31, 2015, this segment operated 735 Sears stores. Sears Holdings Corporation was founded in 1899 and is based in Hoffman Estates, Illinois.

Leucadia National Corporation (LUK) traded within a range of $24.74 to $25.02 after opening the day at $25. The company has seen its stock increase in value by 7.53% so far this year. The stock was up close to 0.36% on active volume in last trading session and closed at $25 per share. After the recent gain, the stock is currently holding 0.24% above its 52 week high of $25.02 and 77.6% above its 12-month low of $14.27. The shares are up by over 20.74% in the last three months, and the RSI indicator value of 64 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Leucadia National Corporation, a diversified holding company, engages in investment banking and capital markets, beef processing, manufacturing, oil and gas exploration and production, and asset management activities. Its services include equities research, sales, and trading; financing, securities lending, and other brokerage; wealth management; fixed income sales and trading; trade execution in foreign exchange, spot, forward, swap, and option contracts across currencies; equity and debt capital markets, as well as financial advisory in the areas of mergers and acquisition, restructuring, and recapitalization; equity and debt financing to companies, financial sponsors, and government entities; and investment management services to pension funds, insurance companies, and other institutional investors. The company also provides investment advisory, portfolio management, and operational services to accredited investors and qualified purchasers; and online foreign exchange trading and related services. In addition, it develops and owns residential and mixed-use real estate properties in California, New York, Florida, Virginia, South Carolina, and Maine; provides capital solutions, investment sales advisory, research, and services for multifamily and commercial properties; and purchases automobile installment contracts, as well as leases used Harley-Davidson motorcycles. Further, it processes and markets beef, beef by-products, pork, and leather; owns oil and gas properties in the Bakken field, as well as leases and develops oil and gas properties in Texas and Oklahoma; owns and operates 27 automobile dealerships; offers fixed wireless broadband services in Italy; manufactures and markets plastic netting and wood products; and mines gold and silver ores. The company was formerly known as Talcott National Corp. and changed its name to Leucadia National Corporation in June 1980. Leucadia National Corporation was founded in 1968 and is headquartered in New York, New York.

 

Stocks In Queue: CEL-SCI Corporation (CVM), Uranium Energy Corp. (UEC), InterCloud Systems, Inc. (ICLD)

CEL-SCI Corporation (CVM) fell -13.27% during last trading as the stock lost $-0.02 to finish the day at $0.13 with about 4.58M shares changing hands, compared to its three month average trading volume of 2.69M. The $24.04M market cap company, which fluctuated between $0.125 and $0.147 during the day, currently situated 116.83% above its 52 week low of $0.06 and -80.29% away from its one year high of $0.66. The RSI of 54.37 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Uranium Energy Corp. (UEC) gained $0.08 to close the day at a new closing price of $1.84, a 4.55% increase in value from its previous closing price that moved the stock 166.67% above its 52 week low of $0.69. A total of 4.48M shares exchanged hands during the day compared with its three month average trading volume of 2.15M. The stock, which fluctuated between $1.75 and $1.92 during the day, currently situated 1.1% above its 52 week high. The stock is up by 9.52% in the past one month and up by 100% over the past three months. With a one year target estimate of $2.81 and RSI of 67.62, the stock still has upside potential, making it a hold for now.

Uranium Energy Corp. engages in the exploration, pre-extraction, extraction, and processing of uranium concentrates on projects located in the United States and the Republic of Paraguay. As of July 31, 2016, it had mineral rights in uranium projects located in the states of Arizona, Colorado, New Mexico, Texas, and Wyoming, as well as in the Republic of Paraguay. The company was formerly known as Carlin Gold Inc. and changed its name to Uranium Energy Corp. in January 2005. Uranium Energy Corp. was incorporated in 2003 and is based in Corpus Christi, Texas.

InterCloud Systems, Inc. (ICLD) had a light trading with around 4.47M shares changing hands compared to its three month average trading volume of 7.13M. The stock traded between $0.018 and $0.02 before closing at the price of $0.02 with -2.06% change on the day. The Shrewsbury New Jersey 07702 based company is currently trading 18.75% above its 52 week low of $0.016 and -81.65% below its 52 week high of $1.15. Both the RSI indicator and target price of 40.71 and $6 respectively, lead us to believe that it should be put on hold over the coming weeks.

InterCloud Systems, Inc. provides end-to-end IT and network solutions to the telecommunications service provider and corporate enterprise markets through cloud platforms and professional services in the United States and internationally. It operates through four segments: Applications and Infrastructure, Professional Services, Managed Services, and Cloud Services. The company offers various services, including platform as a service, infrastructure as a service, database as a service, and software as a service; and network management, 24x7x365 monitoring, security monitoring, and storage and backup services. It also provides software-defined networking (SDN) training, SDN software development and integration, virtualized network functions validation in a multi-vendor environment, unified communications, interactive voice response, and session initiation protocol based call centers, as well as structured cabling and other field installations. In addition, the company designs, engineers, installs, and maintains various types of Wi-Fi and wide-area, distributed antenna system, and small cell distribution networks for incumbent local exchange carriers, telecommunications original equipment manufacturers (OEMs), cable broadband multiple system operators, and enterprise customers, as well as designs, installs, and maintains hardware solutions for the OEMs that support voice, data, and optical networks. Further, it provides consulting and professional staffing solutions to the service-provider and enterprise market in support of IT and next-generation networks comprising project management, network implementation, network installation, network upgrades, rebuilds, maintenance, and consulting services. Additionally, the company’s engineering, design, installation, and maintenance services support the build-out and operation of enterprise, fiber optic, Ethernet, and wireless networks. InterCloud Systems, Inc. was founded in 2006 and is based in Shrewsbury, New Jersey.

 

Eye Catching Stocks: Ciena Corporation (CIEN), CEL-SCI Corporation (CVM), TEGNA Inc. (TGNA)

Ciena Corporation (CIEN) continued its downward trend with the stock declining -1.14% or $-0.28 to close the day at $24.33 on light trading volume of 1.57M shares, compared to its three month average trading volume of 2.72M. The Hanover Maryland 21076 based company has been outperforming the communication equipment group over the past 52 weeks, with the stock gaining 36.92%, compared to the industry which has advanced 4.47% over the same period. With RSI of 53.07, the stock should still continue to rise and get closer to its one year target estimate of $28.39, making it a hold for now.

Ciena Corporation provides equipment, software, and services that support the transport, switching, aggregation, service delivery, and management of voice, video, and data traffic on communications networks worldwide. The company’s Networking Platforms segment offers hardware networking solutions optimized for the convergence of coherent optical transport, optical transport network switching, and packet switching. Its products include 6500 Packet-Optical Platform and the 5430 Reconfigurable Switching System, Waveserver stackable interconnect system, CoreDirector Multiservice Optical Switches, and OTN configuration for the 5410 Reconfigurable Switching System, as well as Z-Series Packet-Optical Platform; 3000 family of service delivery switches and service aggregation switches, and the 5000 family of service aggregation switches, as well as 8700 Packetwave Platform and the Ethernet packet configuration for the 5410 Service Aggregation Switch; and 4200 Advanced Services Platform, Corestream 5100/5200 Advanced Services Platform, Common Photonic Layer, and 6100 Multiservice Optical Platform. This segment also sells operating system software and enhanced software features embedded in each of these products. The company’s Software and Software-Related Services segment offers network management solutions, including the OneControl Unified Management System, ON-Center Network & Service Management Suite, Ethernet Services Manager, Optical Suite Release, and Planet Operate; and Blue Planet network virtualization, service orchestration, and network management software platform, as well as related installation, support, and consulting services. Its Global Services segment provides consulting and network design, installation and deployment, maintenance support, and training services. The company sells its products through direct and indirect sales channels to network operators. Ciena Corporation was founded in 1992 and is headquartered in Hanover, Maryland.

CEL-SCI Corporation (CVM) fell -0.66% during last trading as the stock lost $0 to finish the day at $0.12 with about 1.57M shares changing hands, compared to its three month average trading volume of 2.44M. The $22.61M market cap company, which fluctuated between $0.12 and $0.13 during the day, currently situated 100% above its 52 week low of $0.06 and -81.82% away from its one year high of $0.66. The RSI of 47.57 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

TEGNA Inc. (TGNA) saw its value increase by 0.18% as the stock gained $0.04 to finish the day at a closing price of $22.73. The stock was lighter in trading and has fluctuated between $17.91-$25.38 per share for the past year. The shares, which traded within a range of $22.45 to $22.75 during the day, are up by 16.45% in the past three months and up by 5.16% over the past six months. It is currently trading 4.65% above its 20 day moving average and 2.85% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $25.5 a share over the next twelve months. The current relative strength index (RSI) reading is 66.87. The technical indicator lead us to believe there will be no major movement any time soon, hold.

TEGNA Inc. engages in media and digital businesses in the United States. The company operates in two segments, Media and Digital. It operates 46 television stations that produce local programming, such as news, sports, and entertainment. The company also operates Cars.com, an online destination for automotive consumers that offers information about car shopping, selling, and servicing; CareerBuilder, which provides human capital solutions, such as employment data and labor market analysis software, talent management software, and other advertising and recruitment solutions; G/O Digital that provides digital marketing services for local businesses; and Cofactor, a digital marketing company that enable brands to deliver content. In addition, it offers advertising and marketing solutions. The company serves approximately 90 million customers through its broadcast and digital media platforms. The company was formerly known as Gannett Co., Inc. and changed its name to TEGNA Inc. in June 2015. TEGNA Inc. was founded in 1906 and is headquartered in McLean, Virginia.

 

Stocks To Track: Enphase Energy, Inc. (ENPH), Conagra Brands, Inc. (CAG), CEL-SCI Corporation (CVM)

Enphase Energy, Inc. (ENPH) climbed 7.14% during last trading as the stock added $0.11 to finish the day at $1.65 with about 3.09M shares changing hands, compared to its three month average trading volume of 792.08K. The $90.22M market cap company, currently situated 73.68% above its 52 week low of $0.95 and -51.9% away from its one year high of $3.43. The RSI of 72.77 indicates the stock is overbought at the current levels, sell for now.

Enphase Energy, Inc., together with its subsidiaries, designs, develops, and sells microinverter systems for residential and commercial markets in the United States and internationally. The company’s semiconductor-based microinverter system converts direct current electricity to alternating current (AC) electricity at the individual solar module level. It also offers energy storage systems, including its AC battery; and system monitoring and control services. The company sells its microinverter systems primarily to distributors, as well as directly to large installers through original equipment manufacturers and strategic partners. Enphase Energy, Inc. was founded in 2006 and is headquartered in Petaluma, California.

Conagra Brands, Inc. (CAG) gained $0.1 to close the day at a new closing price of $38.61, a 0.26% increase in value from its previous closing price that moved the stock 33.65% above its 52 week low of $29.55. A total of 3.09M shares exchanged hands during the day compared with its three month average trading volume of 3.66M. The stock, which fluctuated between $38.34 and $38.67 during the day, currently situated -3.4% below its 52 week high. The stock is up by 2.31% in the past one month and up by 4.89% over the past three months. With a one year target estimate of $41.33 and RSI of 52.93, the stock still has upside potential, making it a hold for now.

Conagra Brands, Inc., together with its subsidiaries, operates as a food company in North America. It operates through five segments: Grocery & Snacks, Refrigerated & Frozen, International, Foodservice, and Commercial. The Grocery & Snacks segment primarily provides branded, shelf-stable food products in various retail channels in the United States. The Refrigerated & Frozen segment offers branded, temperature controlled food products in various retail channels in the United States. The International segment primarily provides branded food products, in various temperature states, in retail and foodservice channels outside of the United States. The Foodservice segment offers branded and customized food products, such as meals, entrees, prepared potatoes, sauces, and various custom-manufactured culinary products packaged for sale to restaurants and other foodservice establishments in the United States. The Commercial segment offers commercially branded and private label food and ingredients primarily to commercial, restaurant, foodservice, food manufacturing, and industrial customers. The company markets its products primarily under the Healthy Choice, Hunt’s, Slim Jim, Reddi-wip, Alexia, Blake’s, Frontera, Bertolli, P.F. Chang’s, and Marie Callender’s brands. The company was formerly known as ConAgra Foods, Inc. and changed its name to Conagra Brands, Inc. in November 2016. Conagra Brands, Inc. was founded in 1919 and is headquartered in Chicago, Illinois.

CEL-SCI Corporation (CVM) had a active trading with around 3.08M shares changing hands compared to its three month average trading volume of 2.28M. The stock traded between $0.117 and $0.135 before closing at the price of $0.13 with -1.57% change on the day. The Vienna Virginia 22182 based company is currently trading 108.33% above its 52 week low of $0.06 and -81.06% below its 52 week high of $0.66. Both the RSI indicator and target price of 48.39 and $3 respectively, lead us to believe that it should be put on hold over the coming weeks.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

 

Three Movers to Watch for: The AES Corporation (AES), CEL-SCI Corporation (CVM), Zions Bancorporation (ZION)

The AES Corporation (AES) grew with the stock adding 1.21% or $0.14 to close at $11.72 on light trading volume of 2.74M compared its three months average trading volume of 5.29M. The Arlington Virginia 22203 based company operating under the Electric Utilities industry has been trending up for the last 52 weeks, with the shares price now 37.84% up for the period and up by 0.86% so far this year. With price target of $12.34 and a 48.41% rebound from 52-week low, The AES Corporation has plenty of upside potential, making it a hold with a view buy.

The AES Corporation operates as a diversified power generation and utility company. It owns and/or operates power plants to generate and sell power to customers, such as utilities, industrial users, and other intermediaries. The company also owns and/or operates utilities to generate or purchase, distribute, transmit, and sell electricity to end-user customers in the residential, commercial, industrial, and governmental sectors; and generates and sells electricity on the wholesale market. It uses a range of fuels to generate electricity, including natural gas, coal, hydro, wind, energy storage, oil, diesel, petroleum coke, biomass, landfill gas, and solar. The company owns and/or operates a generation portfolio of approximately 29,352 megawatts. It has operations in the United States, Chile, Colombia, Argentina, Brazil, Mexico, Central America, the Caribbean, Europe, and Asia. The company was formerly known as Applied Energy Services, Inc. and changed its name to The AES Corporation in April 2000. The AES Corporation was founded in 1981 and is headquartered in Arlington, Virginia.

CEL-SCI Corporation (CVM) gained $0.01 to close the day at a new closing price of $0.13, a 2.58% increase in value from its previous closing price that moved the stock 111.67% above its 52 week low of $0.06. A total of 2.74M shares exchanged hands during the day compared with its three month average trading volume of 2.24M. The stock, which fluctuated between $0.125 and $0.145 during the day, currently situated -80.76% below its 52 week high. The stock is up by 27% in the past one month and down by -47.08% over the past three months. With a one year target estimate of $3 and RSI of 49.6, the stock still has upside potential, making it a hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Zions Bancorporation (ZION) shares were up in last trading by 2.05% to $43.85. It experienced lighter than average volume on day. The stock increased in value by almost 1.11% over the past week and grew 3.84% in the past month. It is currently trading 9.5% above its 50 day moving average and 41.69% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -1.08% decrease in value from its one year high of $44.33. The RSI indicator value of 58.74, lead us to believe that it is a hold for now.

Zions Bancorporation, a financial holding company, provides a range of banking and related services in Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The company offers community banking services, such as small and medium-sized business and corporate banking; commercial and residential development, construction, and term lending; retail banking; treasury cash management and related products and services; and residential mortgage servicing and lending. It also provides trust and wealth management services; capital markets services, including municipal finance advisory and underwriting; and investment services. In addition, the company offers personal banking services to individuals, including home mortgages, bankcards, other installment loans, home equity lines of credit, checking accounts, savings accounts, certificates of deposit of various types and maturities, safe deposit facilities, direct deposits, and Internet and mobile banking services. Further, it provides online and traditional brokerage services; small business administration and secondary market agricultural real estate mortgage loans; and bond transfer, stock transfer, and escrow services for corporate customers. As of December 31, 2015, the company operated 450 domestic branches. Zions Bancorporation was founded in 1873 and is headquartered in Salt Lake City, Utah.

 

Eye Catching Stocks: CEL-SCI Corporation (CVM), Intel Corporation (INTC), HP Inc. (HPQ)

CEL-SCI Corporation (CVM) managed to rebound with the stock climbing 38.86% or $0.05 to close the day at $0.16 on active trading volume of 16.73M shares, compared to its three month average trading volume of 1.77M. The Vienna Virginia 22182 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -58.16%, compared to the industry which has dropped -0.36% over the same period. With RSI of 64.12, the stock should still continue to rise and get closer to its one year target estimate of $3, making it a hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Intel Corporation (INTC) fell -0.19% during last trading as the stock lost $-0.07 to finish the day at $36.54 with about 15.9M shares changing hands, compared to its three month average trading volume of 20.44M. The $172.98B market cap company, which fluctuated between $36.53 and $36.93 during the day, currently situated 35.17% above its 52 week low of $27.68 and -4.02% away from its one year high of $38.36. The RSI of 55.35 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through Client Computing Group, Data Center Group, Internet of Things Group, Software and Services, and All Other segments. The company’s platforms are used in various computing applications comprising notebooks, 2 in 1 systems, desktops, servers, tablets, smartphones, wireless and wired connectivity products, wearables, retail devices, and manufacturing devices, as well as for retail, transportation, industrial, buildings, home use, and other market segments. It offers microprocessors that processes system data and controls other devices in the system; chipsets, which send data between the microprocessor and input, display, and storage devices, such as keyboard, mouse, monitor, hard drive or solid-state drive, and optical disc drives; and system-on-chip products that integrate its central processing units with other system components onto a single chip. The company also provides communication and connectivity offerings, such as baseband processors, radio frequency transceivers, and power management integrated circuits; and tablet, phone, and Internet of Things solutions, which include multimode 4G LTE modems, Bluetooth technology and GPS receivers, software solutions, and interoperability tests, as well as home gateway and set-top box components. In addition, it offers security solutions for computers, mobile devices, and networks, as well as software and services for technology integration; NAND flash memory products, which are used in solid-state drives; and custom foundry services, including custom silicon, packaging, and manufacturing test services. The company sells its products primarily to original equipment manufacturers, original design manufacturers, and industrial and communications equipment manufacturers in the computing and communications industries. Intel Corporation was founded in 1968 and is based in Santa Clara, California.

HP Inc. (HPQ) saw its value increase by 0.07% as the stock gained $0.01 to finish the day at a closing price of $14.69. The stock was higher in trading and has fluctuated between $8.91-$16.25 per share for the past year. The shares, which traded within a range of $14.4 to $14.97 during the day, are down by -4.97% in the past three months and up by 8.94% over the past six months. It is currently trading -3.25% below its 20 day moving average and -3.18% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $16.1 a share over the next twelve months. The current relative strength index (RSI) reading is 37.73. The technical indicator lead us to believe there will be no major movement any time soon, hold.

HP Inc. provides products, technologies, software, solutions, and services to individual consumers and small- and medium-sized businesses, as well as to the government, health, and education sectors worldwide. It operates through Personal Systems and Printing segments. The Personal Systems segment offers commercial personal computers (PCs), consumer PCs, workstations, thin clients, commercial tablets and mobility devices, retail point-of-sale systems, displays and other related accessories, software, support, and services for the commercial and consumer markets. The Printing segment provides consumer and commercial printer hardware, supplies, media, solutions, and services, as well as scanning devices; and laserjet and enterprise, inkjet and printing, graphics, and 3D printing solutions. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.

 

Stocks Alert: KeyCorp (KEY), CEL-SCI Corporation (CVM), Macy’s, Inc. (M)

KeyCorp (KEY) retreated with the stock falling -0.33% or $-0.06 to close at $18.26 on active trading volume of 9.48M compared its three months average trading volume of 15.9M. The Cleveland Ohio 44114 based company operating under the Regional – Midwest Banks industry has been trending up for the last 52 weeks, with the shares price now 57.2% up for the period and down by -0.05% so far this year. With price target of $18.88 and a 89.65% rebound from 52-week low, KeyCorp has plenty of upside potential, making it a hold with a view buy.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The company’s Key Community Bank segment offers deposit and investment products; personal finance services and loans, including residential mortgages, home equity, credit cards, and various installment loans for individuals; deposits, investment and credit products, and business advisory services to small businesses; and financial, estate and retirement planning, and asset management services to high-net-worth clients. This segment also provides commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange services to mid-sized businesses. Its Key Corporate Bank segment offers a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans for middle market clients comprising consumer, energy, healthcare, industrial, public, real estate, and technology sectors. In addition, KeyCorp provides personal, securities lending, and custody services; access to mutual funds; treasury, investment banking, international banking, and investment management services; public retirement plans, and foundations and endowments plans; and financial services consisting of community development financing, securities underwriting, and brokerage, as well as merchant services. As of December 31, 2015, the company operated 966 retail banking branches and 1,257 automated teller machines in 12 states, as well as a telephone banking call center. KeyCorp was founded in 1849 and is headquartered in Cleveland, Ohio.

CEL-SCI Corporation (CVM) dropped $0 to close the day at a new closing price of $0.11, a 1.78% increase in value from its previous closing price that moved the stock 90.83% above its 52 week low of $0.06. A total of 9.38M shares exchanged hands during the day compared with its three month average trading volume of 1.63M. The stock, which fluctuated between $0.105 and $0.12 during the day, currently situated -82.65% below its 52 week high. The stock is down by -4.58% in the past one month and down by -59.11% over the past three months. With a one year target estimate of $3 and RSI of 49.36, the stock still has upside potential, making it a hold for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Macy’s, Inc. (M) shares were down in last trading by -1.17% to $30.46. It experienced higher than average volume on day. The stock decreased in value by almost -14.94% over the past week and fell -28.79% in the past month. It is currently trading -21.86% below its 50 day moving average and -16.35% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -32.29% decrease in value from its one year high of $45.5. The RSI indicator value of 22.03, lead us to believe that it may correct downwards in the near term.

Macy’s, Inc., together with its subsidiaries, operates stores, Websites, and mobile applications in the United States. Its stores and Websites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates stores that offer a range of women’s, men’s, and children’s apparel; shoes; fashion accessories; housewares; home textiles; intimate apparel; and jewelry. As of November 14, 2016, it operated approximately 870 stores under the Macy’s, Bloomingdales, Bluemercury, Bloomingdale’s Outlet, and Macy’s Backstage brands, as well as Websites, including macys.com, bloomingdales.com, and bluemercury.com. In addition, it operates as a beauty products and spa retailer. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy’s, Inc. in June 2007. Macy’s, Inc. was founded in 1830 and is based in Cincinnati, Ohio.

 

Stocks Roundup: Netflix, Inc. (NFLX), Kohl’s Corporation (KSS), CEL-SCI Corporation (CVM)

Netflix, Inc. (NFLX) retreated with the stock falling -0.56% or $-0.74 to close at $131.07 on light trading volume of 10.65M compared its three months average trading volume of 8.51M. The Los Gatos California 95032 based company operating under the CATV Systems industry has been trending up for the last 52 weeks, with the shares price now 14.41% up for the period and up by 5.87% so far this year. With price target of $124.35 and a 63.94% rebound from 52-week low, Netflix, Inc. has plenty of upside potential, making it a hold with a view buy.

Netflix, Inc., an Internet television network, engages in the Internet delivery of television (TV) shows and movies on various Internet-connected screens. The company operates in three segments: Domestic streaming, International streaming and Domestic DVD. It offer members with the ability to receive TV shows and movies streaming content, including original series, documentaries, and feature films through a host of Internet-connected screens, such as TVs, digital video players, TV set-top boxes, and mobile devices. The company also provides DVDs-by-mail membership services. As of October 17, 2016, it served approximately 86 million streaming members in 190 countries. Netflix, Inc. was founded in 1997 and is headquartered in Los Gatos, California.

Kohl’s Corporation (KSS) had a light trading with around 10.34M shares changing hands compared to its three month average trading volume of 4.32M. The stock traded between $41.17 and $42.1 before closing at the price of $41.43 with -1.38% change on the day. The Menomonee Falls Wisconsin 53051 based company is currently trading 26.52% above its 52 week low of $33.87 and -30.57% below its 52 week high of $59.67. Both the RSI indicator and target price of  and $51.95 respectively, lead us to believe that it could rise over the coming weeks.

Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers. The company also sells its products online through Website Kohls.com. As of January 30, 2016, it operated 1,164 department stores in 49 states. Kohl’s Corporation was founded in 1962 and is headquartered in Menomonee Falls, Wisconsin.

CEL-SCI Corporation (CVM) saw its value increase by 37.87% as the stock gained $0.03 to finish the day at a closing price of $0.11. The stock was higher in trading and has fluctuated between $0.06-$0.66 per share for the past year. The shares, which traded within a range of $0.0817 to $0.1179 during the day, are down by -58.33% in the past three months and down by -76.06% over the past six months. It is currently trading 23.67% above its 20 day moving average and -38.52% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $3 a share over the next twelve months. The current relative strength index (RSI) reading is 49.02.The technical indicator lead us to believe there will be no major movement any time soon, hold.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

 

3 Stocks in Focus: Macy’s, Inc. (M), CEL-SCI Corporation (CVM), Ares Capital Corporation (ARCC)

Macy’s, Inc. (M) fell -1.32% during last trading as the stock lost $-0.48 to finish the day at $35.81 with about 3.78M shares changing hands, compared to its three month average trading volume of 5.86M. The $11.09B market cap company, which fluctuated between $35.61 and $36.5 during the day, currently situated 23.43% above its 52 week low of $29.94 and -20.4% away from its one year high of $45.5. The RSI of 32.86 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Macy’s, Inc., together with its subsidiaries, operates stores, Websites, and mobile applications in the United States. Its stores and Websites sell a range of merchandise, including apparel and accessories for men, women, and children; cosmetics; home furnishings; and other consumer goods. The company also operates stores that offer a range of women’s, men’s, and children’s apparel; shoes; fashion accessories; housewares; home textiles; intimate apparel; and jewelry. As of November 14, 2016, it operated approximately 870 stores under the Macy’s, Bloomingdales, Bluemercury, Bloomingdale’s Outlet, and Macy’s Backstage brands, as well as Websites, including macys.com, bloomingdales.com, and bluemercury.com. In addition, it operates as a beauty products and spa retailer. The company was formerly known as Federated Department Stores, Inc. and changed its name to Macy’s, Inc. in June 2007. Macy’s, Inc. was founded in 1830 and is based in Cincinnati, Ohio.

CEL-SCI Corporation (CVM) dropped $0 to close the day at a new closing price of $0.07, a -10.28% decrease in value from its previous closing price that moved the stock 12% above its 52 week low of $0.06. A total of 3.78M shares exchanged hands during the day compared with its three month average trading volume of 1.37M. The stock, which fluctuated between $0.0645 and $0.076 during the day, currently situated -89.82% below its 52 week high. The stock is down by -68% in the past one month and down by -78.32% over the past three months. With a one year target estimate of $3 and RSI of 18.1, the stock still has upside potential, making it a buy for now.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Ares Capital Corporation (ARCC) had a active trading with around 3.78M shares changing hands compared to its three month average trading volume of 2.34M. The stock traded between $16.33 and $16.66 before closing at the price of $16.49 with -0.42% change on the day. The New York New York 10167 based company is currently trading 48.21% above its 52 week low of $12.31 and -0.54% below its 52 week high of $16.91. Both the RSI indicator and target price of 67.07 and $16.68 respectively, lead us to believe that it should be put on hold over the coming weeks.

 

Stocks Under Consideration: CEL-SCI Corporation (CVM), Zions Bancorporation (ZION), Diamond Offshore Drilling, Inc. (DO)

CEL-SCI Corporation (CVM) retreated with the stock falling -1.58% or $-0.01 to close at $0.07 on active trading volume of 1.55M compared its three months average trading volume of 1.36M. The Vienna Virginia 22182 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -79.76% down for the period and down by -79.76% so far this year. With price target of $3 and a 24.83% rebound from 52-week low, CEL-SCI Corporation has plenty of upside potential, making it a hold with a view buy.

CEL-SCI Corporation engages in the research and development of drugs and vaccines. Its lead investigational immunotherapy is Multikine, which is under pivotal phase III clinical trial for the treatment of primary head and neck cancer. The company’s Multikine is also used in a Phase I study with the Naval Medical Center, San Diego under a cooperative research and development agreement in HIV/HPV co-infected men and women with peri-anal warts. Its Ligand Epitope Antigen Presentation System, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza in hospitalized patients; and CEL-2000 and CEL-4000 vaccine product candidates for the treatment of rheumatoid arthritis. CEL-SCI Corporation was founded in 1983 and is headquartered in Vienna, Virginia.

Zions Bancorporation (ZION) had a light trading with around 1.55M shares changing hands compared to its three month average trading volume of 3.21M. The stock traded at the price of $42.79 with -1.13% change on the day. The Salt Lake City Utah 84133 based company is currently trading 119.97% above its 52 week low of $19.65 and -3.08% below its 52 week high of $44.15. Both the RSI indicator and target price of  and $41.56 respectively, lead us to believe that it could rise over the coming weeks.

Zions Bancorporation, a financial holding company, provides a range of banking and related services in Arizona, California, Colorado, Idaho, Nevada, New Mexico, Oregon, Texas, Utah, Washington, and Wyoming. The company offers community banking services, such as small and medium-sized business and corporate banking; commercial and residential development, construction, and term lending; retail banking; treasury cash management and related products and services; and residential mortgage servicing and lending. It also provides trust and wealth management services; capital markets services, including municipal finance advisory and underwriting; and investment services. In addition, the company offers personal banking services to individuals, including home mortgages, bankcards, other installment loans, home equity lines of credit, checking accounts, savings accounts, certificates of deposit of various types and maturities, safe deposit facilities, direct deposits, and Internet and mobile banking services. Further, it provides online and traditional brokerage services; small business administration and secondary market agricultural real estate mortgage loans; and bond transfer, stock transfer, and escrow services for corporate customers. As of December 31, 2015, the company operated 450 domestic branches. Zions Bancorporation was founded in 1873 and is headquartered in Salt Lake City, Utah.

Diamond Offshore Drilling, Inc. (DO) saw its value increase by 0.17% as the stock gained $0.03 to finish the day at a closing price of $17.88. The stock was lighter in trading and has fluctuated between $14.18-$26.72 per share for the past year. The shares, which traded within a range of $17.73 to $17.98 during the day, are up by 0.34% in the past three months and down by -26.51% over the past six months. It is currently trading -6.95% below its 20 day moving average and 0.9% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $17.34 a share over the next twelve months. The current relative strength index (RSI) reading is 44.16.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Diamond Offshore Drilling, Inc. provides contract drilling services to the energy industry worldwide. It provides services in floater market, including ultra-deepwater, deepwater, and mid-water. The company operates a fleet of 32 offshore drilling rigs, which comprise 8 ultra-deepwater, 7 deepwater, and 8 mid-water semisubmersibles; 5 jack-ups; and 4 drillships. It serves independent oil and gas companies, and government-owned oil companies. The company was founded in 1989 and is headquartered in Houston, Texas. Diamond Offshore Drilling, Inc. operates as a subsidiary of Loews Corporation.